NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.42B
1-Year Est. Return 12.08%
This Quarter Est. Return
1 Year Est. Return
+12.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.93B
AUM Growth
-$321M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$150M
2
+$16M
3
+$5.46M
4
FOLD icon
Amicus Therapeutics
FOLD
+$5.37M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$4.57M

Top Sells

1
+$53M
2
+$43.1M
3
+$33.7M
4
INZY
Inozyme Pharma
INZY
+$31.8M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$26.9M

Sector Composition

1 Healthcare 57.28%
2 Financials 8.56%
3 Technology 7.59%
4 Consumer Discretionary 1.65%
5 Communication Services 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$429M 22.21%
1,933,900
2
$166M 8.56%
3,826,253
+22,380
3
$150M 7.77%
+3,463,577
4
$147M 7.59%
1,037,404
5
$116M 6.01%
2,050,446
-595,000
6
$92.7M 4.8%
5,587,207
7
$84.9M 4.39%
4,840,413
8
$77.7M 4.02%
2,793,864
9
$57M 2.95%
225,200
10
$48.7M 2.52%
2,445,147
11
$46.5M 2.41%
1,079,320
-1,000,000
12
$40.6M 2.1%
104,583
13
$31.8M 1.65%
214,827
14
$28.8M 1.49%
15,873
-10,025
15
$28.2M 1.46%
600,000
-193,265
16
$27.2M 1.41%
3,522,019
17
$27.1M 1.4%
4,514,336
18
$25.6M 1.32%
343,038
19
$24.4M 1.26%
2,560,211
+562,331
20
$20.6M 1.07%
836,518
+161,358
21
$20.3M 1.05%
197,000
22
$19.9M 1.03%
2,459,021
23
$19.7M 1.02%
3,327,312
24
$19.2M 0.99%
695,840
25
$17.3M 0.89%
1,099,478
-14,368
1
2 3